Cost-effectiveness analysis of p53 immunohistochemical testing in stage I and II high-risk endometrial cancer.

被引：0
|
作者：
Orellana, Taylor
Berger, Jessica L.
Boisen, Michelle M.
Buckanovich, Ronald J.
Coffman, Lan Gardner
Courtney-Brooks, Madeleine
Edwards, Robert P.
Mahdi, Haider
Olawaiye, Alexander
Sukumvanich, Paniti
Vargo, John
Bhargava, Rohit
Beriwal, Sushil
Taylor, Sarah E.
Smith, Kenneth
Lesnock, Jamie Lee
机构：
[1] UPMC, Magee Womens Hosp, Pittsburgh, PA USA
[2] UPMC, Hillman Canc Ctr, Pittsburgh, PA USA
[3] Univ Pittsburgh, Pittsburgh, PA USA
[4] Univ Pittsburgh, Med Ctr Canc Ctr, Pittsburgh, PA USA
[5] Univ Pittsburgh, UPMC Hillman Canc Ctr, Dept Radiat Oncol, Sch Med, Pittsburgh, PA USA
[6] Univ Pittsburgh, Med Ctr, Dept Med, Pittsburgh, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e18838
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18838
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Cost-Effectiveness Analysis of Treatment Strategies for Stage I and II Endometrial Cancer
    Kwon, Janice S.
    Carey, Mark S.
    Goldie, Sue J.
    Kim, Jane J.
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2007, 29 (02) : 131 - 139
  • [2] Cost-effectiveness analysis of tumor molecular classification in high-risk early-stage endometrial cancer
    Orellana, T. J.
    Kim, H.
    Beriwal, S.
    Bhargava, R.
    Berger, J.
    Buckanovich, R. J.
    Coffman, L. G.
    Courtney-Brooks, M.
    Mahdi, H.
    Olawaiye, A. B.
    Sukumvanich, P.
    Taylor, S. E.
    Smith, K. J.
    Lesnock, J. L.
    [J]. GYNECOLOGIC ONCOLOGY, 2022, 164 (01) : 129 - 135
  • [3] Cost-effectiveness of POLE testing for high intermediate risk endometrial cancer
    Lee, Sarah
    Chen, Ling
    Prest, Matthew
    Chalas, Eva
    Boyd, Leslie
    Wright, Jason
    [J]. GYNECOLOGIC ONCOLOGY, 2023, 176 : S280 - S281
  • [4] Cost-effectiveness analysis of tumor molecular testing in stage III endometrial cancer
    Orellana, Taylor J.
    Kim, Hayeon
    Beriwal, Sushil
    Taylor, Sarah E.
    Smith, Kenneth J.
    Lesnock, Jamie L.
    [J]. GYNECOLOGIC ONCOLOGY, 2023, 173 : 81 - 87
  • [5] Cost-effectiveness analysis of tumor molecular testing in stage III endometrial cancer
    Orellana, Taylor
    Kim, Hayeon
    Berger, Jessica
    Bhargava, Rohit
    Boisen, Michelle
    Buckanovich, Ronald
    Coffman, Lan
    Courtney-Brooks, Madeleine
    Edwards, Robert
    Mahdi, Haider
    Olawaiye, Alexander
    Sukumvanich, Paniti
    Taylor, Sarah
    Smith, Kenneth
    Beriwal, Sushil
    Lesnock, Jamie
    [J]. GYNECOLOGIC ONCOLOGY, 2022, 166 : S60 - S60
  • [6] Cost-Effectiveness Analysis of Tumor Molecular Classification in High-Risk Early-Stage Endometrial Cancer EDITORIAL COMMENT
    Van Le, Linda
    [J]. OBSTETRICAL & GYNECOLOGICAL SURVEY, 2022, 77 (04) : 214 - 216
  • [7] Cost-effectiveness of adjuvant chemotherapy for high-risk stage II and stage III colon cancer in South Africa
    Tan, Sarah Xinhui
    Pumpalova, Yoanna
    Rogers, Alexandra M. M.
    Bhatt, Kishan
    Herbst, Candice-lee
    Ruff, Paul
    Neugut, Alfred I. I.
    Hur, Chin
    [J]. CANCER MEDICINE, 2023, 12 (14): : 15515 - 15529
  • [8] Serum p53 antibody as a diagnostic marker of high-risk endometrial cancer
    Yamazawa, Koji
    Shimada, Hideaki
    Hirai, Makiko
    Hirashiki, Koichiro
    Ochiai, Takenori
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 197 (05) : 505.e1 - 505.e7
  • [9] Cost-effectiveness of abiraterone acetate for high-risk nnon-metastatic prostate cancer.
    Lester-Coll, Nataniel Hernan
    Ahmed, Shahid Sattar
    Wallace, H. James
    Sprague, Brian L.
    Ades, Steven
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [10] Evaluation of p53 immunohistochemical expression in high-risk colorectal adenomas
    Naranjo-Hans, D.
    Iglesias Coma, M.
    Navarro Viu, G.
    Gimeno Beltran, J.
    Masso Castella, J.
    Torner Calvo, A.
    Alvarez Urturi, A. C.
    Carot Bastard, L.
    Andreu Garcia, M.
    Lloveras Rubio, B.
    [J]. VIRCHOWS ARCHIV, 2017, 471 : S188 - S189
12345